BU-NOT-SET

CONTACT US
Optimising formulation to improve solubility ready for Phase III
  • Drug product
Optimising formulation
Case study
Trends emerging in capsule dosage form development
  • Drug product
  • Industry trends
Capsules
Insight
Licensing portfolio
  • Corporate
containers
Fact sheet
Key trends in pharmaceutical outsourcing
  • Industry trends
Hands
Insight
The latest trends and innovations in oral drug delivery
  • Drug product
  • Industry trends
Pharma Roundtable
Insight
Recipharm invests in African vaccine production
  • Corporate
Building
Insight
The future of oral solid dose development and manufacturing
  • Drug product
  • Industry trends
Products
Insight
Sustainability Report 2021
  • Sustainability
Sustainability report
Report
Treating long-COVID with Erdosteine
  • Corporate
Treating long-COVID with Erdosteine
Insight
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products
Insight
  • Manufacturing
FDA inspection success at Recipharm’s site in Bengaluru, India
Fact sheet
  • Drug product
  • Manufacturing
Lyophilisation Services
Insight
  • Drug product
  • Manufacturing
Using blow-fill-seal technology for biologic and vaccine delivery
Webinar
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials